Publications by authors named "Shui He"

Claim this Profile
S
Study on the regulation of gastric cancer cell apoptosis by LACTB through mitochondrial autophagy pathway.
Wei Nie, Lihua Hu, Zhiqiang Yan, Qian Wang, Shui He

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causal Associations between Particulate Matter 2.5 (PM ), PM Absorbance, and Inflammatory Bowel Disease Risk: Evidence from a Two-Sample Mendelian Randomization Study.
Xu Zhang, Zhi Meng Wu, Lu Zhang, Bing Long Xin, Xiang Rui Wang, Shui Xiang He

Biomed Environ Sci· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A potential therapeutic approach for gastric cancer: inhibition of LACTB transcript 1.
Wei Nie, Lihua Hu, Zhiqiang Yan, Yang Wang, Qianyun Shi, Shui He

Aging (Albany NY)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical guideline on magnetically controlled capsule gastroscopy (2021 edition).
Bin Jiang, Jun Pan, Yang Yang Qian, Chen He, Ji Xia, Shui Xiang He, Jia Yu Chen, Xue Qiang He, Ling He, Feng Lin Chen, Zhen Li, Chao Hui He, Jian Sheng Wu, Bai Li Chen, Chun Sheng Cheng, Zhi Zheng Ge, Zhao Shen Li

J Dig Dis· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of lubiprostone for the treatment of functional constipation in Chinese adult patients: A multicenter, randomized, double-blind, placebo-controlled trial.
Ying Lian Xiao, Ning Dai, Shui Xiang He, De An Tian, Si De Liu, Wei Zheng Zeng, Xi Zhong Shen, Min Hu Chen

J Dig Dis· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial.
Paolo F Caimi, Weiyun Ai, Juan Pablo Alderuccio, Kirit M Ardeshna, Mehdi Hamadani, Brian Hess, Melhem Solh, Shui He

Lancet Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study.
Mehdi Hamadani, Graham P Collins, Paolo F Caimi, Felipe Samaniego, Alexander Spira, Shui He

Lancet Haematol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody-Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma.
Brad S Kahl, Mehdi Hamadani, John Radford, Carmelo Carlo-Stella, Paolo Caimi, Melhem Solh, Leonard T Heffner, Shui He

Clin Cancer Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert consensus on perioperative medications during endoscopic submucosal dissection for gastric lesions (2015, Suzhou, China).
Yu Bai, Jian Ting Cai, You Xiang Chen, Fei Gao, Xiao Zhong Guo, Shui Xiang He, Zhen Dong Jin, Zhao Shen Li, He Sheng Luo, Jian Qiu Sheng, Zhen Yu Zhang

J Dig Dis· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chinese expert consensus on the endoscopic management of foreign bodies in the upper gastrointestinal tract (2015, Shanghai, China).
Jin Huan Lin, Jun Fang, Dong Wang, He Zhong Chen, Qiang Guo, Li Ping He, Shui Xiang He, Zhen Dong Jin, Hong Liang Zheng, Zhao Shen Li

J Dig Dis· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ruxolitinib versus standard therapy for the treatment of polycythemia vera.
Alessandro M Vannucchi, Jean Jacques Kiladjian, Martin Griesshammer, Tamas Masszi, Simon Durrant, Pierre Zachee, Shui He

N Engl J Med· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 Inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea.
Srdan Verstovsek, Francesco Passamonti, Alessandro Rambaldi, Giovanni Barosi, Peter J Rosen, Shui He

Cancer· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lactate versus non-lactate metabolic acidosis: a retrospective outcome evaluation of critically ill patients.
Kyle J Gunnerson, Melissa Saul, Shui He, John A Kellum

Crit Care· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective investigation of PM10 in ambient air and cardiopulmonary hospital admissions in Allegheny County, Pennsylvania: 1995-2000.
Vincent C Arena, Sati Mazumdar, Jeanne V Zborowski, Evelyn O Talbott, Shui He

J Occup Environ Med· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis